|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/496 | |
| A61P 15/00 |
| (11) | Number of the document | 1740180 |
| (13) | Kind of document | T |
| (96) | European patent application number | 05735420.1 |
| Date of filing the European patent application | 2005-04-18 | |
| (97) | Date of publication of the European application | 2007-01-10 |
| (45) | Date of publication and mention of the grant of the patent | 2010-07-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/EP2005/004086 |
| Date | 2005-04-18 |
| (87) | Number | WO 2005/102343 |
| Date | 2005-11-03 |
| (30) | Number | Date | Country code |
| 564660 P | 2004-04-22 | US |
| (72) |
PYKE, Robert, US
|
| (73) |
Boehringer Ingelheim Pharmaceuticals, Inc.,
900 Ridgebury Road, Ridgefield Connecticut 06877,
US
Boehringer Ingelheim Pharma GmbH & Co. KG, Binger Strasse 173, 55216 Ingelheim, DE |
| (54) | USE OF FLIBANSERIN IN THE TREATMENT OF PREMENSTRUAL DISORDERS |
| USE OF FLIBANSERIN IN THE TREATMENT OF PREMENSTRUAL DISORDERS |